Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
The Lancet. Haematology|February 5, 2024
Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 studyAlex Bataller, Guillermo Montalban-Bravo, Alexandre Bazinet, et al.Oncotarget|March 9, 2018
Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasmsGuillermo Montalban-Bravo, Koichi Takahashi, Keyur Patel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2021
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic SyndromesAziz Nazha, Rami Komrokji, Manja Meggendorfer, et al.Blood|November 16, 2006
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1John D Shaughnessy, Fenghuang Zhan, Bart E Burington, et al.Cancer Research|March 5, 2015
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancerPiergiorgio Pettazzoni, Andrea Viale, Parantu Shah, et al.Cancer Cell|July 4, 2017
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple MyelomaMatteo Marchesini, Yamini Ogoti, Elena Fiorini, et al.Biorxiv : the Preprint Server for Biology|August 30, 2024
A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid LeukemiaSamarpana Chakraborty, Claudia Morganti, Bianca Rivera Pena, et al.Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
PAF promotes stemness and radioresistance of glioma stem cellsDerrick Sek Tong Ong, Baoli Hu, Yan Wing Ho, et al.Proceedings of the National Academy of Sciences of the United States of America|July 13, 2021
Telomere dysfunction instigates inflammation in inflammatory bowel diseaseDeepavali Chakravarti, Rumi Lee, Asha S Multani, et al.Cancer Discovery|October 11, 2011
PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine networkHaoqiang Ying, Kutlu G Elpek, Anant Vinjamoori, et al.Pageof 10